Vivalis strengthens its management team with the appointment of Philippe Rousseau, as Chief Financial Officer VIVALIS (PARIS: VLS), a biopharmaceutical company that provides the pharmaceutical ...
NANTES, FRANCE--(Marketwire - June 8, 2010) - VIVALIS (NYSE Euronext: VLS) announced today the signature with Sanofi Pasteur, the vaccines division of sanofi-aventis Group (Euronext: SAN and NYSE: SNY ...
PARIS, Nov 24 (Reuters) - French biotech Vivalis and its British partner GlaxoSmithKline have won U.S. clearance to begin testing for the first time on humans flu vaccines that were produced using ...
France's Vivalis is buying Austrian vaccines specialist Intercell in a deal the firms say will result in the "creation of a European biotech leader". France’s Vivalis is buying Austrian vaccines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results